Heron Therapeutics Inc vs OneSpan Inc — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while OneSpan Inc trades at $16.25 (market cap $600.69M). The key difference: OneSpan Inc is far larger — about 9.8× Heron Therapeutics Inc's market cap, and OneSpan Inc pays a 3.19% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | OSPN | |
|---|---|---|
Market Cap | $61.47M | $600.69M |
Sector | Health | Technology |
52-Week High | $1.49 | $16.78 |
52-Week Low | $0.32 | $10.15 |
Enterprise Value | $168.21M | $569.77M |
Dividend Yield | — | 3.19% |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →